Santen Pharmaceutical Co., Ltd. and the University College London (UCL) have formed a collaboration for ophthalmic research and education.
Through the collaboration, Santen will reportedly conduct research programs with scientists in the UCL Institute of Ophthalmology and provide PhD candidates with funding support. The arrangement will reportedly help provide a framework for both parties to work together on ophthalmic research that can ultimately be translated into therapies, as well as allow both parties to collaborate on capability and talent development in various fields of ophthalmology.
Click here to read the full press release.
Source: University College London